Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 20, 2022 14:40 ET | Source: Straits Research

TB Diagnostics Market Size is projected to reach USD 2.14 Billion by 2030, growing at a CAGR of 5.56%: Straits Research

New York, United States, July 20, 2022 (GLOBE NEWSWIRE) -- The global TB diagnostics market had a market share of USD 1,337.30 million in 2021, according to the new report of Straits Research. It is...
August 10, 2011 05:00 ET | Source: Immune Network Ltd

Immune Network to Start Clinical Trial of Oral Mycobacterium Vaccae in Tuberculosis Patients

VANCOUVER, British Columbia, Aug. 10, 2011 (GLOBE NEWSWIRE) -- Immune Network Ltd., (Pink Sheets:IMMFF), reports that its business partner Immunitor company has launched a Phase 2 clinical trial of a...
July 07, 2011 10:33 ET | Source: Immune Network Ltd

Herbal TB Immunotherapy to be Presented at Hong Kong Conference

VANCOUVER, British Columbia, July 7, 2011 (GLOBE NEWSWIRE) -- Immune Network Ltd. (Pink Sheets:IMMFF) advises that clinical results from its new tableted form of Immunoxel (Dzherelo) product...
May 30, 2011 10:14 ET | Source: Immune Network Ltd

TB Immunotherapy Collaboration Agreement With Stirling Products and Zodiac Capital

Agreement to fast-track introduction of new Immunoxel/Dzherelo tablet as adjunct immunotherapy, especially for MDR-TB VANCOUVER, British Columbia, May 30, 2011 (GLOBE NEWSWIRE) -- Immune...
February 28, 2011 06:22 ET | Source: Immune Network Ltd

Immunitor Presents Positive TB Treatment Data at African Conference

VANCOUVER, B.C., Feb. 28, 2011 (GLOBE NEWSWIRE) -- Immune Network Ltd. (Pink Sheets:IMMFF) advises that Immunitor will present latest results from its imm01 clinical trial in tuberculosis patients in...
January 24, 2011 04:43 ET | Source: Immune Network Ltd

Immunitor Releases Positive Results of TB Immunotherapy From Its Second Clinical Site

VANCOUVER, British Columbia, Jan. 24, 2011 (GLOBE NEWSWIRE) -- Immune Network Ltd., (Pink Sheets:IMMFF) a company in the business of development and commercialization of immune therapies, announced...
December 30, 2010 04:41 ET | Source: Immune Network Ltd

Immunitor Publishes Interim Data From Phase IIb imm01 TB Trial

VANCOUVER, British Columbia, Dec. 30, 2010 (GLOBE NEWSWIRE) -- Immune Network Ltd. (Pink Sheets:IMMFF), advises that Immunitor has published data from the first half of the 120-patient imm01 clinical...
November 01, 2010 09:42 ET | Source: Immune Network Ltd

Immunitor Phase 2b imm01 Trial Enrollment Scheduled to Complete Next Week

VANCOUVER, British Columbia, Nov. 1, 2010 (GLOBE NEWSWIRE) -- Immune Network Ltd. (Pink Sheets:IMMFF), a company in the business of discovery and development of immune-based therapies, today announced...